QUANTERIX CORP

Profile

Company Names

QUANTERIX CORP

Addresses

900 MIDDLESEX TURNPIKE, BILLERICA, MA 01821

113 HARTWELL AVE, LEXINGTON, MA 02421

ONE KENDALL SQUARE, SUITE B14201, CAMBRIDGE, MA 02139

Phone Numbers

617-301-9400

 

Entity Type:

CORPORATION

Industry:

OTHER TECHNOLOGY, OTHER, OTHER HEALTH CARE

Year Incorporated:

2007

State Incorporated:

DELAWARE

Total Amount Raised:

$71,757,356.00

Number of Funding Rounds:

7
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
7
2019-07-01 
$6,175,000.00 
$6,500,000.00 
$325,000.00 
Equity 
6
2017-06-02 
$8,499,999.00 
$8,499,999.00 
$0.00 
Equity 
5
2016-03-18 
$45,582,361.00 
$45,582,362.00 
$1.00 
Equity 
4
2013-12-03 
$999,999.00 
$999,999.00 
$0.00 
Equity 
3
2012-03-01 
$1,999,999.00 
INDEFINITE 
INDEFINITE 
Debt 
2
2011-08-15 
$5,999,998.00 
INDEFINITE 
INDEFINITE 
Equity 
1
2010-09-28 
$2,500,000.00 
$5,000,000.00 
$2,500,000.00 
 
People
First Name
Middle Name
Last Name
Titles
Related Companies
PAUL 
 
CHAPMAN 
EXECUTIVE OFFICER, DIRECTOR
SILVER LAKE RESOURCES LTD   |  QUANTERIX CORP   |  INTERPHASE MEDICAL EQUIPMENT, INC.   |  CHC MEDICAL PARTNERS, INC.
AMOL 
 
CHAUBAL 
EXECUTIVE OFFICER
GREAT LAKES POWER LTD   |  QUANTERIX CORP   |  REDSHIFT BIOANALYTICS, INC.
DOUGLAS 
 
COLE 
DIRECTOR
AVEO PHARMACEUTICALS INC   |  TETRAPHASE PHARMACEUTICALS INC   |  RESOLVYX PHARMACEUTICALS, INC.   |  SELECTA BIOSCIENCES INC   |  QUANTERIX CORP   |  LS22, INC.   |  SYROS PHARMACEUTICALS, INC.   |  EDITAS MEDICINE, INC.   |  SANA BIOTECHNOLOGY, INC.
DOUGLAS 
G. 
COLE 
DIRECTOR
QUANTERIX CORP   |  TORQUE THERAPEUTICS, INC.
JOHN 
 
CONNOLLY 
DIRECTOR
LUMIGENT TECHNOLOGIES INC   |  M|C ACQUISITION CORP.   |  AQUION ENERGY, INC.   |  LOGICSOURCE, INC.   |  BAIN CAPITAL VENTURE FUND 2012, L.P.   |  BCV 2012 PRIVATE INVESTORS, L.P.   |  AMEC PLC   |  SCOREBIG, INC.   |  ECOSENSE LIGHTING INC.   |  QUANTERIX CORP   |  TECOSTAR HOLDINGS, INC.   |  BCV 2014 PRIVATE INVESTORS, L.P.   |  BAIN CAPITAL VENTURE COINVESTMENT FUND, L.P.   |  BAIN CAPITAL VENTURE FUND 2014, L.P.   |  ANEXINET HOLDING COMPANY, INC.   |  PAYCOR, INC   |  7PARK DATA, INC.   |  LIQUIDX, INC.   |  CLOUD GURU GROUP INC.   |  IBOSS, INC.   |  SPECTRUM EQUITY LS, L.P.   |  PRESENCELEARNING HOLDINGS, INC.   |  WIN REALITY, INC.   |  SPECTRUM EQUITY X-B, L.P.   |  SPECTRUM EQUITY X-C, L.P.   |  SPECTRUM EQUITY DISCRETIONARY OVERAGE PROGRAM III-B, L.P.   |  SPECTRUM EQUITY DISCRETIONARY OVERAGE PROGRAM III-A, L.P.   |  SPECTRUM EQUITY X-A, L.P.   |  SPECTRUM X INVESTMENT MANAGERS- FUND, L.P.   |  MAGUIRE HAYDEN REAL ESTATE CO III, L.P.   |  EAG HOLDINGS LP   |  LIMBLE SOLUTIONS, INC.   |  GRAHAM INCOME TRUST   |  QFD INVESTOR, L.P.
JOHN 
M. 
CONNOLLY 
DIRECTOR
MEMENTO INC   |  DYNAMICS INC.   |  PAYCOR, INC   |  2020, INC.   |  QUANTERIX CORP
KEITH 
 
CRANDELL 
DIRECTOR
ADESTO TECHNOLOGIES CORP   |  UNIVA CORP   |  CRYSTAL IS INC   |  NANOSYS INC   |  CIESPACE CORP   |  908 DEVICES INC.   |  TWIST BIOSCIENCE CORP   |  QUANTERIX CORP   |  BOREAL GENOMICS INC.   |  PIXELEXX SYSTEMS, INC.   |  NANOSYS, INC.   |  ARBOR BIOTECHNOLOGIES, INC.   |  ULTIVUE, INC.   |  VIZGEN, INC.
KEITH 
L. 
CRANDELL 
DIRECTOR
QUANTERIX CORP   |  NEWCO LS15, INC.   |  PERMEON BIOLOGICS, INC.   |  ARCH VENTURE FUND VIII, L.P.   |  ARCH VENTURE FUND IX, L.P.   |  ARCH VENTURE FUND X, L.P.   |  ARCH VENTURE FUND X OVERAGE, L.P.   |  CYTRELLIS BIOSYSTEMS, INC.   |  ARCH VENTURE FUND XI, L.P.   |  ARCH VENTURE FUND XII, L.P.
MARIJN 
 
DEKKERS 
DIRECTOR
QUANTERIX CORP   |  ENKO CHEM, INC.   |  ANIMOL DISCOVERY, INC.   |  FLYWHEEL EXCHANGE INC.
JOSEPH 
 
DRISCOLL 
EXECUTIVE OFFICER
SUMMER INFANT, INC.   |  QUANTERIX CORP   |  YM SOL SOILS I LLC
PHILLIP 
 
GARDELLA 
EXECUTIVE OFFICER
QUANTERIX CORP
E. 
KEVIN 
HRUSOVSKY 
EXECUTIVE OFFICER, DIRECTOR
QUANTERIX CORP
KEVIN 
 
HRUSOVSKY 
EXECUTIVE OFFICER, DIRECTOR
908 DEVICES INC.   |  QUANTERIX CORP
MARTIN 
 
MADAUS 
EXECUTIVE OFFICER, DIRECTOR
QUANTERIX CORP   |  JAGUAR HOLDING CO I   |  EMULATE, INC.   |  SYNTIS BIO, INC.
MARTIN 
D. 
MADAUS 
DIRECTOR
QUANTERIX CORP
PAUL 
 
MEISTER 
DIRECTOR
MAGNOLIA MEDICAL TECHNOLOGIES, INC.   |  QUANTERIX CORP   |  GCM GROSVENOR CALIFORNIA IMPACT SBIC FUND, L.P.   |  CIC-FPRT ABSOLUTE RETURN PORTFOLIO, LTD.   |  SAN GABRIEL FUND 3, L.P.   |  GCM PATRIOT, LLC   |  GCM GROSVENOR OPPORTUNISTIC CREDIT FUND V, LTD.   |  GCM TRIBE, LLC   |  TITANIUM F2 FUND, LTD   |  GCM RANGER, LLC   |  GROSVENOR OPPORTUNISTIC MULTI-STRATEGY FUND, L.P.   |  GROSVENOR INSTITUTIONAL PARTNERS (PF), LTD.   |  GCM GROSVENOR SPECIAL OPPORTUNITIES FUND, L.P.   |  VTV THERAPEUTICS INC.   |  MCG ALTSCAPE FUND, L.P   |  KUMANU, INC.   |  ACTIV SURGICAL, INC.   |  MERCY BIOANALYTICS, INC.   |  ARBOR BIOTECHNOLOGIES, INC.   |  LUMACYTE, INC.   |  NOVALIS LIFESCIENCES INVESTMENTS II, L.P.   |  PERFECT AIR HOLDCO LLC   |  PANTHER MANAGEMENT HOLDCO LLC   |  LEVITASBIO, INC.   |  UPKARA INC.   |  TELESIS BIO INC.   |  AMBIENT BIOSCIENCES, INC.   |  BLUEWHALE BIO, INC.   |  FLYWHEEL EXCHANGE INC.   |  GCM GROSVENOR CREDIT SECONDARIES STRUCTURED NOTE 2025, L.P.   |  GCM GROSVENOR CREDIT SECONDARIES STRUCTURED NOTE 2025 FEEDER, L.P.   |  EVEREST BIOLABS, INC.
PAUL 
M. 
MEISTER 
DIRECTOR
INVENTIV GROUP HOLDINGS, INC.   |  INVENTIV HEALTH INC   |  QUANTERIX CORP
JAMES 
 
NAHIRNY 
DIRECTOR
SYNAPDX CORP.   |  QUANTERIX CORP   |  HUMEDICA, INC.   |  LEERINK REVELATION HEALTHCARE FUND I, L.P.   |  HCI CLEANING PRODUCTS, LLC   |  LOGICSOURCE, INC.   |  VALERA HEALTH, INC.   |  BIOCIRCUIT TECHNOLOGIES, INC.
DAVID 
 
OKRONGLY 
EXECUTIVE OFFICER, DIRECTOR
QUANTERIX CORP   |  EXOSOME DIAGNOSTICS, INC.   |  BRAVA DIAGNOSTICS, INC.   |  AUTONOMOUS MEDICAL DEVICES INC
ERNEST 
 
ORITICERIO 
EXECUTIVE OFFICER
QUANTERIX CORP
ERNEST 
 
ORTICERIO 
EXECUTIVE OFFICER
QUANTERIX CORP
DENNIS 
 
SANDSTEDT 
DIRECTOR
QUANTERIX CORP
DAVID 
 
WALT 
DIRECTOR
QUANTERIX CORP   |  AURASENSE THERAPEUTICS, LLC   |  SHERLOCK BIOSCIENCES, INC.   |  VIZGEN, INC.   |  ARBOR BIOTECHNOLOGIES, INC.   |  PROTILLION BIOSCIENCES, LNC.   |  EVEREST BIOLABS, INC.
DAVID 
R. 
WALT 
DIRECTOR
ULTIVUE, INC.   |  EXICURE, INC.   |  CERULEAN PHARMA INC.   |  ARBOR BIOTECHNOLOGIES, INC.   |  EXICURE, INC.   |  QUANTERIX CORP
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2019-07-11
D
Link
OTHER TECHNOLOGY 
LABORATORY ANALYTICAL INSTRUMENTS [3826] 
DECLINE TO DISCLOSE 
Equity 
2019-07-01 
2017-06-14
D
Link
OTHER 
 
DECLINE TO DISCLOSE 
Equity 
2017-06-02 
2016-03-31
D
Link
OTHER 
 
DECLINE TO DISCLOSE 
Equity 
2016-03-18 
2013-12-17
D
Link
OTHER 
 
DECLINE TO DISCLOSE 
Equity 
2013-12-03 
2012-03-06
D
Link
OTHER HEALTH CARE 
 
DECLINE TO DISCLOSE 
Debt 
2012-03-01 
2011-08-19
D
Link
OTHER HEALTH CARE 
 
DECLINE TO DISCLOSE 
Equity 
2011-08-15 
2010-10-12
D
Link
OTHER HEALTH CARE 
 
DECLINE TO DISCLOSE 
 
2010-09-28 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#